Hui RT - Search Results

1

[Moving forward to the next "seek treasures" frontier: precision cardiovascular medicine].

Hui RT, Song L, Kong T, Wang JZ, Zou YB, Liu Z, Hou Q. Hui RT, et al. Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Mar 24;47(3):253-258. doi: 10.3760/cma.j.issn.0253-3758.2019.03.016. Zhonghua Xin Xue Guan Bing Za Zhi. 2019. PMID: 30897890 Chinese.

2

A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.

Huang X, Song L, Ma AQ, Gao J, Zheng W, Zhou X, Zhang Q, Lu H, Li Y, Liu Y, Hui R. Huang X, et al. Clin Chim Acta. 2001 Aug 20;310(2):131-9. doi: 10.1016/s0009-8981(01)00538-1. Clin Chim Acta. 2001. PMID: 11498078

3

[Relationship between calpain-10 gene polymorphism, hypertension and plasma glucose].

Hong J, Li G, Li C, Hui R, Sun S, Wang J, Ye J, Cai H. Hong J, et al. Zhonghua Nei Ke Za Zhi. 2002 Jun;41(6):370-3. Zhonghua Nei Ke Za Zhi. 2002. PMID: 12137596 Chinese.

4

Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.

Lu Y, Zhao Y, Liu G, Wang X, Liu Z, Chen B, Hui R. Lu Y, et al. Thromb Res. 2002 Apr 1;106(1):7-12. doi: 10.1016/s0049-3848(02)00064-6. Thromb Res. 2002. PMID: 12165282

5

Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults.

Zou Y, Song L, Wang Z, Ma A, Liu T, Gu H, Lu S, Wu P, Zhang dagger Y, Shen dagger L, Cai Y, Zhen double dagger Y, Liu Y, Hui R. Zou Y, et al. Am J Med. 2004 Jan 1;116(1):14-8. doi: 10.1016/j.amjmed.2003.05.009. Am J Med. 2004. PMID: 14706660

6

[Clinical and genetic characteristics of a Chinese family of primary pulmonary hypertension].

Jing ZC, Lu LH, Zou YB, You SJ, Han ZY, Zhang Q, Yang YJ, Hui RT, Cheng XS. Jing ZC, et al. Among authors: hui rt. Zhonghua Yi Xue Za Zhi. 2004 Feb 2;84(3):199-202. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15059534 Chinese.

7

Mutations profile in Chinese patients with hypertrophic cardiomyopathy.

Song L, Zou Y, Wang J, Wang Z, Zhen Y, Lou K, Zhang Q, Wang X, Wang H, Li J, Hui R. Song L, et al. Clin Chim Acta. 2005 Jan;351(1-2):209-16. doi: 10.1016/j.cccn.2004.09.016. Clin Chim Acta. 2005. PMID: 15563892

8

[Correlation of thrombospondin-1 G1678A polymorphism to stroke: a study in Chinese population].

Liu XN, Song L, Wang DW, Liao YH, Ma AQ, Zhu ZM, Zhao BR, Zhao JZ, Hui RT. Liu XN, et al. Among authors: hui rt. Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1959-62. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15730804 Chinese.

9

MYBPC3 polymorphism is a modifier for expression of cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Wang P, Zou Y, Fu C, Zhou X, Hui R. Wang P, et al. Biochem Biophys Res Commun. 2005 Apr 8;329(2):796-9. doi: 10.1016/j.bbrc.2005.02.004. Biochem Biophys Res Commun. 2005. PMID: 15737656 Clinical Trial.

10

Plasma homocysteine thiolactone adducts associated with risk of coronary heart disease.

Yang X, Gao Y, Zhou J, Zhen Y, Yang Y, Wang J, Song L, Liu Y, Xu H, Chen Z, Hui R. Yang X, et al. Clin Chim Acta. 2006 Feb;364(1-2):230-4. doi: 10.1016/j.cccn.2005.07.007. Epub 2005 Aug 18. Clin Chim Acta. 2006. PMID: 16111668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters